Zealand Pharma A/S 2018 SR
The report outlines Zealand Pharma's commitment to corporate social responsibility for the 2018 fiscal year, focusing on its transition into a fully integrated biotech company. Key highlights include the commitment to six UN Sustainable Development Goals, a strong emphasis on employee engagement with an 85% survey response rate, and achieving 50% female representation on the Board of Directors. The company also details its patient-centric approach, quality management through vendor oversight, and ethical standards including a whistleblower program. Environmental efforts focus on minimizing impact through responsible consumption, despite having no manufacturing facilities.
Company: Zealand Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2018
Type: SR
Pages: 20
Back to company
Zealand Pharma A/S
Corporate Social Responsibility Report
The report outlines Zealand Pharma's commitment to corporate social responsibility for the 2018 fiscal year, focusing on its transition into a fully integrated biotech company. Key highlights include the commitment to six UN Sustainable Development Goals, a strong emphasis on employee engagement with an 85% survey response rate, and achieving 50% female representation on the Board of Directors. The company also details its patient-centric approach, quality management through vendor oversight, and ethical standards including a whistleblower program. Environmental efforts focus on minimizing impact through responsible consumption, despite having no manufacturing facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees